CoChat

Germline MC1R status influences somatic mutation burden in melanoma

Open access
Robles-Espinoza, Carla Daniela, Roberts, Nicola D., Chen, Shuyang, Leacy, Finbarr P., Alexandrov, Ludmil B., Pornputtapong, Natapol, Halaban, Ruth, Krauthammer, Michael, Cui, Rutao, Timothy Bishop, D., Adams, David J. · 2016 · Nature Communications

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

The major genetic determinants of cutaneous melanoma risk in the general population are disruptive variants ( R alleles) in the melanocortin 1 receptor ( MC1R ) gene. These alleles are also linked to red hair, freckling, and sun sensitivity, all of which are known melanoma phenotypic risk factors. Here we report that in melanomas and for somatic C>T mutations, a signature linked to sun exposure, the expected single-nucleotide variant count associated with the presence of an R allele is estimated to be 42% (95% CI, 15–76%) higher than that among persons without an R allele. This figure is comparable to the expected mutational burden associated with an additional 21 years of age. We also find significant and similar enrichment of non-C>T mutation classes supporting a role for additional mutagenic processes in melanoma development in individuals carrying R alleles.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms12064

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The distribution of SNV counts detected through exome sequencing of melanoma samples. SNV counts are grouped by the presence of R alleles of the MC1R locus, and are shown as a boxplot with median, quartiles, whiskers and outliers. For each SNV class, the blue dashed line (and ribbon) charts the predicted mean mutation burden (and 95% confidence interval) of a patient with the most common constellation of values for clinical variables as the R allele count increases from zero to one or two, with all other clinical variables held fixed. (a) TCGA melanoma cohort, in which the most common constellation represents a 57-year-old male from the University of Sydney collection centre, with a metastasis to a regional lymph node of the extremities and a primary Breslow depth of 2.5 mm, Clark level IV, and no ulceration. Please note that one sample, TCGA-FW-A3R5, with R genotype 0/0 is an outlier with more than 10,000 C>T somatic mutations and is not depicted in the C>T panel of this image. (b) Yale Melanoma Project cohort, in which the most common constellation represents a 65 year-old male sampled via a metastasis.
Figure 1 The distribution of SNV counts detected through exome sequencing of melanoma samples. SNV counts are grouped by the presence of R alleles of the MC1R locus, and are shown as a boxplot with median, quartiles, whiskers and outliers. For each SNV class, the blue dashed line (and ribbon) charts the predicted mean mutation burden (and 95% confidence interval) of a patient with the most common constellation of values for clinical variables as the R allele count increases from zero to one or two, with all other clinical variables held fixed. (a) TCGA melanoma cohort, in which the most common constellation represents a 57-year-old male from the University of Sydney collection centre, with a metastasis to a regional lymph node of the extremities and a primary Breslow depth of 2.5 mm, Clark level IV, and no ulceration. Please note that one sample, TCGA-FW-A3R5, with R genotype 0/0 is an outlier with more than 10,000 C>T somatic mutations and is not depicted in the C>T panel of this image. (b) Yale Melanoma Project cohort, in which the most common constellation represents a 65 year-old male sampled via a metastasis.CC BY · PubMed Central
Figure 2 MC1R expression regulates the formation of mutagenic photoproducts. (a) Shown are HPMs stably expressing control shRNA (shScr) or multiple independent shMC1Rs targeting MC1R (#1, #2, #3). Cells were pre-incubated with 1 μM α-MSH for 30 min, then exposed to 100 J m−2 UVB light, and harvested 3 h later for Western blot analysis. (b) HPM cells stably expressing shMC1R#1 were irradiated with different doses of UVB light as indicated. Cells were collected at 24 h after UVB light irradiation and viability assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. (c) HPMs stably expressing an shRNA against MC1R (shMC1R#1) or a scrambled control (ShScr) were transfected with 2 μg of UV damaged pGL3 luciferase expression vector and 0.5 μg pRL Renilla Luciferase control reporter vector before the host cell reactivation assay2832 (Methods section; d,e). HPMs stably expressing an shRNA against MC1R (shMC1R#1) or a scrambled control (ShScr) were irradiated with 100 J m−2 UVB light and then collected at the different time points indicated. Genomic DNA was extracted and photoproducts were detected by ELISA. Cyclobutane pyrimidine dimer (CPD) (d) or 6–4 pyrimidine photoproduct (6–4PP) (e) antibodies were used (Methods section). These data were compiled from three separate experiments performed in triplicate. Significance (*P<0.05) was calculated by using the unpaired two-tailed Student's t-test comparing the means (shScr vs shMC1R#1) of the three experiments. Error bars represent s.d.
Figure 2 MC1R expression regulates the formation of mutagenic photoproducts. (a) Shown are HPMs stably expressing control shRNA (shScr) or multiple independent shMC1Rs targeting MC1R (#1, #2, #3). Cells were pre-incubated with 1 μM α-MSH for 30 min, then exposed to 100 J m−2 UVB light, and harvested 3 h later for Western blot analysis. (b) HPM cells stably expressing shMC1R#1 were irradiated with different doses of UVB light as indicated. Cells were collected at 24 h after UVB light irradiation and viability assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. (c) HPMs stably expressing an shRNA against MC1R (shMC1R#1) or a scrambled control (ShScr) were transfected with 2 μg of UV damaged pGL3 luciferase expression vector and 0.5 μg pRL Renilla Luciferase control reporter vector before the host cell reactivation assay2832 (Methods section; d,e). HPMs stably expressing an shRNA against MC1R (shMC1R#1) or a scrambled control (ShScr) were irradiated with 100 J m−2 UVB light and then collected at the different time points indicated. Genomic DNA was extracted and photoproducts were detected by ELISA. Cyclobutane pyrimidine dimer (CPD) (d) or 6–4 pyrimidine photoproduct (6–4PP) (e) antibodies were used (Methods section). These data were compiled from three separate experiments performed in triplicate. Significance (*P<0.05) was calculated by using the unpaired two-tailed Student's t-test comparing the means (shScr vs shMC1R#1) of the three experiments. Error bars represent s.d.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 48 references

Cited by

See all 124

Metadata

Authors
Robles-Espinoza, C. D., Roberts, N. D., Chen, S., Leacy, F. P., Alexandrov, L. B., Pornputtapong, N., Halaban, R., Krauthammer, M., Cui, R., Timothy Bishop, D., & Adams, D. J.
Affiliations
  • Wellcome Sanger Institute (GB)
  • Boston University (US)
  • Royal College of Surgeons in Ireland (IE)
  • Yale University (US)
Corresponding author
Adams, David J.
Venue
Nature Communications
Published
2016-07-12
Volume
7
Issue
1
Pages
12064-12064
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2474228978
Cited by
124
References
48
Citations by year
2026: 3 · 2025: 4 · 2024: 11 · 2023: 15 · 2022: 5 · 2021: 10 · 2020: 15 · 2019: 20 · 2018: 18 · 2017: 18 · 2016: 5
FWCI
10.95
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Yale University (P50 CA121974)
  • Wellcome Trust
  • Cancer Research UK (13031, 10589, 19167)
  • National Institutes of Health (UL1TR001863)
  • National Cancer Institute (P50CA121974)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
MC1R, germline mutations, somatic mutation burden, cutaneous melanoma, sun exposure, mutational signatures, C>T mutations, melanoma risk
MeSH terms
Mutation Accumulation, Aged, Alleles, Female, Hair Color, Head and Neck Neoplasms, Humans, Male, Melanoma, Melanosis, Middle Aged, Mutation, Neoplasm Invasiveness, Skin Neoplasms, Skin Pigmentation, Genetic Variation, Cohort Studies, Germ-Line Mutation, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Receptor, Melanocortin, Type 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.